- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01377948
Reducing Aggression in Children and Adolescent on an Inpatient Unit
March 8, 2012 updated by: Gonzalez-Heydrich, Joseph, M.D.
Phase 1 Study of Anger Control Therapy Augmented With RAGE-Control (Regulate and Gain Emotional-Control)Delivered on an Inpatient Psychiatric Unit
The purpose of this study is to determine whether Anger Control Therapy (ACT) with Regulate and Gain Emotional-Control (RAGE-Control) is a feasible behavioral therapy to provide on a pediatric inpatient psychiatric unit.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Aggression and disruptive behavior are the most common reasons for child and adolescent inpatient psychiatric hospitalization.
Aggressive children and adolescents who merit admission to inpatient psychiatric hospitals for treatment typically display dramatic problems with self-regulation that interfere with global adaptive functioning.
The goal of this study is to teach self-regulation techniques by combining Cognitive Behavioral Therapy with a biofeedback video game in effort to motivate patients to learn and practice these coping skills, which will translate to decreased feelings of anger and aggression while hospitalized.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Children's Hospital Boston
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years to 17 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- consecutive admissions to the psychiatric inpatient unit between the ages of 9 and 17 years of age
- who were not expected to begin or undergo a change >25% to their antipsychotic or mood stabilizing medications
- elevated levels of anger as demonstrated by baseline score on the State Trait Anger Expression Inventory - Child and Adolescent (STAXI-CA) combined State-anger and Trait-anger score greater than 30.
Exclusion Criteria:
- Inability to consent, comprehend, and effectively participate in the study.
- Gross cognitive impairment due to mental retardation, dementia, or intoxication.
- Started on an antipsychotic or mood stabilizing drug within 5 days of beginning the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: ACT with RAGE-Control
all subjects are assigned to this arm.
This is an open feasability proof of concept trail with a single experimental group with all subjects receiving the intervention being studied.
|
This is an open trial of ACT with RAGE-Control which is a behavioral intervention.
The therapy involves five psychotherapy sessions taking place over five consecutive days.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change from baseline in State Trait Anger Expression Inventory - Child and Adolescent
Time Frame: change from baseline to just after 5th daily session of the study treatment
|
change from baseline to just after 5th daily session of the study treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Percentage of time playing videogame with heart rate under preset threshold
Time Frame: During videogame play at end of each of the 5 daily sessions of the study treatment
|
During videogame play at end of each of the 5 daily sessions of the study treatment
|
|
Therapeutic Helpfulness Questionnaire
Time Frame: after session number 5 of the 5 daily study treatment sessions
|
To provide information about feasibility, ratings of perceived helpfulness were collected using the Therapeutic Helpfulness Questionnaire5, which elicits both quantitative and qualitative data in three dimensions: 1) the degree to which it is helpful versus hurtful 2) the degree to which the focus of the treatment was helpful 3) overall satisfaction with the treatment.
Participants rated each item from 1 = very unhappy or unhelpful to 7 = very happy or helpful.
|
after session number 5 of the 5 daily study treatment sessions
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Elizabeth Wharff, PhD, Boston Children's Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2010
Primary Completion (Actual)
September 1, 2011
Study Completion (Actual)
October 1, 2011
Study Registration Dates
First Submitted
June 15, 2011
First Submitted That Met QC Criteria
June 20, 2011
First Posted (Estimate)
June 22, 2011
Study Record Updates
Last Update Posted (Estimate)
March 12, 2012
Last Update Submitted That Met QC Criteria
March 8, 2012
Last Verified
March 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- X10-06-0278
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anger
-
Ege UniversityCompleted
-
naomi goldsteinNational Institute of Mental Health (NIMH)Completed
-
Walter Reed Army Institute of Research (WRAIR)Enrolling by invitation
-
Florida State UniversityCompletedAnger | Smoking CessationUnited States
-
Karolinska InstitutetCompletedInappropriate Anger ExpressionSweden
-
University of Colorado, DenverChildren's Hospital ColoradoNot yet recruitingAnger | Irritable Mood | Temper Tantrum
-
VA Office of Research and DevelopmentCompleted
-
VA Office of Research and DevelopmentCompleted
-
University of SheffieldUniversity of ManchesterCompletedAnger | AggressionUnited Kingdom
-
Massachusetts General HospitalHarvard University; American Academy of Child Adolescent Psychiatry.UnknownAnger | AggressionUnited States
Clinical Trials on ACT with RAGE-Control
-
Gonzalez-Heydrich, Joseph, M.D.UnknownAnger | AggressionUnited States
-
Massachusetts General HospitalHarvard University; American Academy of Child Adolescent Psychiatry.UnknownAnger | AggressionUnited States
-
Tel Aviv UniversityCompleted
-
George Washington UniversityUniversity of Oklahoma; Addis Ababa University; Pathfinder International; Overseas... and other collaboratorsActive, not recruiting
-
The Hong Kong Polytechnic UniversityHospital Authority, Hong KongCompletedChildhood AsthmaHong Kong
-
Tel Aviv UniversityCompleted
-
University of Alabama at BirminghamParalyzed Veterans of AmericaRecruitingDepression | Spinal Cord InjuriesUnited States
-
University of NottinghamUnknownCarer Stress SyndromeUnited Kingdom
-
Hospices Civils de LyonCompleted
-
Baylor College of MedicineUS Department of Veterans AffairsRecruitingPelvic Pain | Distress, EmotionalUnited States